NYSE Exchanges Remove Position Limits for 11 Crypto ETF Options

iconTechFlow
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
NYSE Arca and NYSE American have lifted the 25,000-contract position limits for options market products linked to 11 crypto ETFs, including IBIT, FBTC, and ARKB. The change, effective immediately following SEC approval, eliminates the 30-day waiting period. This adjustment aligns the regulatory framework with that of commodity ETF options, supporting ETF inflows and enhancing institutional trading efficiency.

According to Cointelegraph, NYSE Arca and NYSE American, subsidiaries of the New York Stock Exchange, have officially removed the 25,000-contract position limit on options linked to 11 cryptocurrency exchange-traded funds (ETFs). The regulatory change has received a 30-day waiver from the U.S. Securities and Exchange Commission (SEC) and is effective immediately. The affected ETFs include BlackRock’s iShares Bitcoin Trust (IBIT), Fidelity’s Wise Origin Bitcoin Fund (FBTC), ARK 21Shares Bitcoin ETF (ARKB), as well as Bitcoin and Ethereum ETFs from Bitwise and Grayscale. These position limits were initially established in November 2024 upon the launch of options on cryptocurrency ETFs to guard against market manipulation and excessive volatility. With their removal, the regulatory treatment of these options will align with that of other commodity ETF options, enhancing trading flexibility for institutional investors and potentially improving market liquidity.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.